The Research Institute at Nationwide Children’s Hospital enhances the health of children by engaging in high quality, cutting-edge research that results in better ways to prevent, screen for, diagnose, or treat pediatric diseases. Conducting clinical trials is a key step in translating these lab discoveries into standard clinical practice.
The Food and Drug Administration closely regulates human participation in clinical trials involving new drugs and devices. Drug and Device Development Services guides investigators through this complex submission, review and approval process. We provide a streamlined, uniform and consistent approach to development and implementation of clinical trials.
Drug and Device Development Services resides within the Center for Clinical and Translational Research at Nationwide Children’s Hospital Research Institute. We exist to help our medical faculty and investigators get from pre-clinical to clinical trials, as well as guide external partners and collaborators through the regulatory landscape.
Our services focus on ensuring your success through:
View or print a fact-sheet with a detailed breakdown of our services.
Please visit this web site often for additional tools, resources and education materials on Investigative New Drug and Investigative Device Exemption applications.
Christopher J. Shilling, MS
Director, Drug and Device Development and Services
Phone: (614) 355-3574
FAX: (614) 722-3273